Opposite effects of iv amiodarone on cardiovascular vagal and sympathetic efferent activities in rats (Q44066866)

29 November 2017

title

Opposite effects of iv amiodarone on cardiovascular vagal and sympathetic efferent activities in rats (English)

1 reference

29 November 2017

1 reference

Valdo Jose Dias Da Silva

1

1 reference

29 November 2017

Tomaso Gnecchi-Ruscone

2

1 reference

29 November 2017

Barbara Lavelli

3

1 reference

29 November 2017

Valentina Bellina

4

1 reference

29 November 2017

Daniela Manzella

5

1 reference

29 November 2017

Alberto Porta

6

1 reference

29 November 2017

Alberto Malliani

7

1 reference

29 November 2017

Nicola Montano

8

1 reference

29 November 2017

language of work or name

1 reference

1 August 2002

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

29 November 2017

published in

1 reference

29 November 2017

volume

283

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

R543-8

1 reference

The effects of amiodarone, an α and β receptor antagonist, on adrenergic transmission in the cat spleen

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

Single cardiac vagal fiber activity, acute myocardial ischemia, and risk for sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

Evidence-based analysis of amiodarone efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

Autonomic influences in atrial tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

21 January 2018

Intravenous amiodarone

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

Neural mechanisms in life-threatening arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

Amiodarone pharmacokinetics. I. Acute dose-dependent disposition studies in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00608.2001

10.1152/AJPREGU.00608.2001

21 January 2018

Identifiers

DOI

0 references

1 reference